Title:
HETEROCYCLIC GLP-1 AGONISTS
Document Type and Number:
WIPO Patent Application WO/2023/169456
Kind Code:
A1
Abstract:
This disclosure relates to GLP-1 agonists, pharmaceutical compositions, and methods of use thereof.
Inventors:
LIN XICHEN (CN)
MENG QINGHUA (CN)
XING WEIQIANG (CN)
XU ZHONGMIAO (CN)
MENG QINGHUA (CN)
XING WEIQIANG (CN)
XU ZHONGMIAO (CN)
Application Number:
PCT/CN2023/080254
Publication Date:
September 14, 2023
Filing Date:
March 08, 2023
Export Citation:
Assignee:
GASHERBRUM BIO INC (US)
LIN XICHEN (CN)
LIN XICHEN (CN)
International Classes:
A61K31/343; C07D471/04; A61K31/407; A61P3/04; A61P3/10; A61P9/00; C07D273/02; C07D307/80; C07D309/04; C07D333/72; C07D487/14
Domestic Patent References:
| WO2020103815A1 | 2020-05-28 | |||
| WO2018109607A1 | 2018-06-21 | |||
| WO2020234726A1 | 2020-11-26 | |||
| WO2020044266A1 | 2020-03-05 | |||
| WO2010140092A1 | 2010-12-09 | |||
| WO2010128425A1 | 2010-11-11 | |||
| WO2010128414A1 | 2010-11-11 | |||
| WO2010106457A2 | 2010-09-23 | |||
| WO2010103437A1 | 2010-09-16 | |||
| WO2010103438A1 | 2010-09-16 | |||
| WO2010013161A1 | 2010-02-04 | |||
| WO2007122482A1 | 2007-11-01 | |||
| WO2006112549A1 | 2006-10-26 | |||
| WO2007028135A2 | 2007-03-08 | |||
| WO2008047821A1 | 2008-04-24 | |||
| WO2008050821A1 | 2008-05-02 | |||
| WO2008136428A1 | 2008-11-13 | |||
| WO2008156757A1 | 2008-12-24 | |||
| WO2005116034A1 | 2005-12-08 | |||
| WO2010011439A2 | 2010-01-28 | |||
| WO2010023594A1 | 2010-03-04 | |||
| WO2009144554A1 | 2009-12-03 | |||
| WO2003072197A1 | 2003-09-04 | |||
| WO2009144555A1 | 2009-12-03 | |||
| WO2008065508A1 | 2008-06-05 | |||
| WO2001014372A2 | 2001-03-01 | |||
| WO2004039365A1 | 2004-05-13 | |||
| WO1997010224A1 | 1997-03-20 | |||
| WO2000001389A1 | 2000-01-13 | |||
| WO2002006234A1 | 2002-01-24 | |||
| WO2004048363A1 | 2004-06-10 | |||
| WO2005030740A1 | 2005-04-07 | |||
| WO2005058823A1 | 2005-06-30 | |||
| WO2005113504A1 | 2005-12-01 | |||
| WO2010086820A1 | 2010-08-05 | |||
| WO2020117987A1 | 2020-06-11 | |||
| WO2007013694A1 | 2007-02-01 | |||
| WO2007018314A2 | 2007-02-15 | |||
| WO2008093639A1 | 2008-08-07 | |||
| WO2008099794A1 | 2008-08-21 | |||
| WO2004041266A1 | 2004-05-21 | |||
| WO2004106276A1 | 2004-12-09 | |||
| WO2005063729A1 | 2005-07-14 | |||
| WO2005063725A1 | 2005-07-14 | |||
| WO2005087710A1 | 2005-09-22 | |||
| WO2005095338A1 | 2005-10-13 | |||
| WO2007013689A1 | 2007-02-01 | |||
| WO2008001931A2 | 2008-01-03 | |||
| WO2021155841A1 | 2021-08-12 |
Foreign References:
| US10370426B2 | 2019-08-06 | |||
| US10308700B2 | 2019-06-04 | |||
| US10259823B2 | 2019-04-16 | |||
| US10208019B2 | 2019-02-19 | |||
| US9920106B2 | 2018-03-20 | |||
| US9839664B2 | 2017-12-12 | |||
| US8129343B2 | 2012-03-06 | |||
| US8536122B2 | 2013-09-17 | |||
| US7919598B2 | 2011-04-05 | |||
| US6414126B1 | 2002-07-02 | |||
| US6628343B1 | 2003-09-30 | |||
| USRE45313E | 2014-12-30 | |||
| US20060275288A1 | 2006-12-07 | |||
| US20120021979A1 | 2012-01-26 | |||
| US20120148586A1 | 2012-06-14 | |||
| US8859577B2 | 2014-10-14 | |||
| US20050287100A1 | 2005-12-29 | |||
| US20180051012A1 | 2018-02-22 | |||
| US5612359A | 1997-03-18 | |||
| US6043265A | 2000-03-28 |
Other References:
KARLA ET AL.: "Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future", INDIAN J ENDOCRINOL METAB., vol. 20, no. 2, pages 254 - 267
"Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
"Pharmaceutical Preformulation and Formulation", 2009, THE PHARMACEUTICAL PRESS AND THE AMERICAN PHARMACEUTICAL ASSOCIATION
ZHANG ET AL., DRUG DISCOVERY TODAY., vol. 12, no. 9-10, 2007, pages 373 - 381
SKELLY ET AL., J HEPATOL, vol. 35, 2001, pages 195 - 9
CHITTURI ET AL., HEPATOLOGY, vol. 35, no. 2, 2002, pages 373 - 9
ANGULO ET AL., J GASTROENTEROL HEPATOL, vol. 17, 2002, pages 186 - 90
BERHMAN REKLIEGMAN RARVIN AMNELSON WE. NELSON: "Textbook of Pediatrics", 1996, W.B. SAUNDERS COMPANY
RUDOLPH AM ET AL.: "Rudolph's Pediatrics", 2002, MCGRAW-HILL
AVERY MD: "Pediatric Medicine", 1994, WILLIAMS & WILKINS
VIRDEE ET AL., OPHTHALMOL THER., vol. 9, no. 4, 2020, pages 767 - 781
SEPPA ET AL., SCI REP, vol. 9, 2019, pages 15742
"Pharmaceutical Dosage Forms: Parenteral Medications", vol. 1-2, 2012, AMERICAN PHARMACEUTICAL ASSOCIATION
T. W. GREENEG. M. WUTS: "Protecting Groups in Organic Synthesis", 1999, WILEY
"Fieser and Fieser's Reagents for Organic Synthesis", vol. 1-40, 1991, JOHN WILEY, AND SONS
RODD'S CHEMISTRY OF CARBON COMPOUNDS, vol. 1-5
"Larock's Comprehensive Organic Transformations", 1989, ELSEVIER SCIENCE PUBLISHERS
"March's Advanced Organic Chemistry", 2001, JOHN WILEY, AND SONS
"Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
"Pharmaceutical Preformulation and Formulation", 2009, THE PHARMACEUTICAL PRESS AND THE AMERICAN PHARMACEUTICAL ASSOCIATION
ZHANG ET AL., DRUG DISCOVERY TODAY., vol. 12, no. 9-10, 2007, pages 373 - 381
SKELLY ET AL., J HEPATOL, vol. 35, 2001, pages 195 - 9
CHITTURI ET AL., HEPATOLOGY, vol. 35, no. 2, 2002, pages 373 - 9
ANGULO ET AL., J GASTROENTEROL HEPATOL, vol. 17, 2002, pages 186 - 90
BERHMAN REKLIEGMAN RARVIN AMNELSON WE. NELSON: "Textbook of Pediatrics", 1996, W.B. SAUNDERS COMPANY
RUDOLPH AM ET AL.: "Rudolph's Pediatrics", 2002, MCGRAW-HILL
AVERY MD: "Pediatric Medicine", 1994, WILLIAMS & WILKINS
VIRDEE ET AL., OPHTHALMOL THER., vol. 9, no. 4, 2020, pages 767 - 781
SEPPA ET AL., SCI REP, vol. 9, 2019, pages 15742
"Pharmaceutical Dosage Forms: Parenteral Medications", vol. 1-2, 2012, AMERICAN PHARMACEUTICAL ASSOCIATION
T. W. GREENEG. M. WUTS: "Protecting Groups in Organic Synthesis", 1999, WILEY
"Fieser and Fieser's Reagents for Organic Synthesis", vol. 1-40, 1991, JOHN WILEY, AND SONS
RODD'S CHEMISTRY OF CARBON COMPOUNDS, vol. 1-5
"Larock's Comprehensive Organic Transformations", 1989, ELSEVIER SCIENCE PUBLISHERS
"March's Advanced Organic Chemistry", 2001, JOHN WILEY, AND SONS
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF: